Foamix Pharma Ord
(FOMX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,771 | -14,384 | -29,336 | -18,505 | -12,701 |
| Depreciation Amortization | 91 | 44 | 143 | 103 | 66 |
| Accounts receivable | 2,369 | -392 | -2,889 | -2,022 | -342 |
| Other Working Capital | 8,367 | 1,466 | -1,104 | 1,704 | -702 |
| Other Operating Activity | -839 | 1,213 | 5,816 | 4,091 | 1,570 |
| Operating Cash Flow | $-20,783 | $-12,053 | $-27,370 | $-14,629 | $-12,109 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -8,000 | -13,207 | -23,000 | -700 | -13,000 |
| PPE Investments | -774 | -280 | -424 | -302 | -216 |
| Purchase Of Investment | -2,913 | -2,913 | -31,700 | -13,000 | -700 |
| Sale Of Investment | 46,922 | 23,273 | 40,106 | 34,134 | 27,725 |
| Investing Cash Flow | $35,235 | $6,873 | $-15,018 | $20,132 | $13,809 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -476 | -476 | -476 |
| Common Stock Issued | 145 | 137 | 55,539 | 51,804 | N/A |
| Other Financing Activity | -16 | -8 | -32 | -24 | -16 |
| Financing Cash Flow | $129 | $129 | $55,031 | $51,304 | $-492 |
| Exchange Rate Effect | 56 | 18 | 2 | 3 | 3 |
| Beginning Cash Position | 31,440 | 31,440 | 18,795 | 18,795 | 18,795 |
| End Cash Position | 46,077 | 26,407 | 31,440 | 75,605 | 20,006 |
| Net Cash Flow | $14,637 | $-5,033 | $12,645 | $56,810 | $1,211 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,783 | -12,053 | -27,370 | -14,629 | -12,109 |
| Capital Expenditure | -774 | -280 | -424 | -302 | -216 |
| Free Cash Flow | -21,557 | -12,333 | -27,794 | -14,931 | -12,325 |